Literature DB >> 12919399

Ring chromosome 14 with localization-related epilepsy: three cases.

Masafumi Morimoto1, Tomohiro Usuku, Masayuki Tanaka, Osamu Otabe, Akira Nishimura, Masaharu Ochi, Yoshihiro Takeuchi, Hiroshi Yoshioka, Tohru Sugimoto.   

Abstract

Three patients showing epileptic seizures and with mosaicism of ring chromosome 14 and monosomy for chromosome 14 are described. Patients were a 17-year-old boy, karyotype 46, XY, r(14)(p12q32.33)/45, XY, -14, a 7-month-old boy, karyotype 46, XY, r(14)(p11.2q32.33)/45, XY, -14, and a 10-month-old boy, karyotype 46, XY, r(14)(p12q32.31)/45, XY, -14. Microcephaly and alopecia were observed in the first patient. However, few dysmorphic features were found typical of ring 14 chromosome. He had exhibited complex partial seizures with secondary generalization at age 3 months and had mild motor and mental retardation. Both other patients had atonic seizures followed by staring, perioral cyanosis, and respiratory arrest at age 7 or 8 months. Both also showed mild developmental delay and had a few minor anomalies compatible with ring 14 chromosome. Interictal spikes were observed in the second patient in the right occipital region, whereas an interictal encephalogram of the third patient showed sporadic spikes in the left central region. In all three cases, seizures were resistant to common antiepileptic drugs.

Entities:  

Mesh:

Year:  2003        PMID: 12919399     DOI: 10.1046/j.1528-1157.2003.05403.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  2 in total

1.  Application of array-based comparative genomic hybridization to pediatric neurologic diseases.

Authors:  Jung Hye Byeon; Eunsim Shin; Gun-Ha Kim; Kyungok Lee; Young Sook Hong; Joo Won Lee; Baik-Lin Eun
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

2.  Dysregulation of FOXG1 by ring chromosome 14.

Authors:  Daniela Alosi; Laura Line Klitten; Mads Bak; Helle Hjalgrim; Rikke Steensbjerre Møller; Niels Tommerup
Journal:  Mol Cytogenet       Date:  2015-04-09       Impact factor: 2.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.